CEMQ:XETRA:XETRA-iShares Edge MSCIope Quality Factor UCITS (EUR)

ETF | Others |

Last Closing

USD 10.16

Change

+0.13 (+1.32)%

Market Cap

USD 0.53B

Volume

0.02M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-26 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

-0.34 (-0.66%)

USD 450.46B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

-0.12 (-0.73%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

-0.19 (-0.69%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

-0.20 (-0.71%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

-0.09 (-0.35%)

USD 157.79B
TM5:XETRA T-MOBILE US INC.DL-00001

-0.34 (-0.23%)

USD 126.93B
8R80:XETRA Amundi Index Solutions - Amund..

-0.58 (-0.41%)

USD 104.09B
JARI:XETRA Amundi Index Solutions - Amund..

-0.27 (-0.61%)

USD 101.29B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

-0.35 (-0.68%)

USD 85.64B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+3.56 (+0.71%)

USD 80.38B

ETFs Containing CEMQ:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 4.24% 49% F 51% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 4.24% 48% F 50% F
Trailing 12 Months  
Capital Gain 8.80% 50% F 54% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 8.80% 49% F 53% F
Trailing 5 Years  
Capital Gain 51.21% 72% C 72% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 51.21% 72% C 70% C-
Average Annual (5 Year Horizon)  
Capital Gain 9.11% 73% C 71% C-
Dividend Return 9.11% 73% C 69% C-
Total Return N/A 8% B- 15% F
Risk Return Profile  
Volatility (Standard Deviation) 13.65% 47% F 57% F
Risk Adjusted Return 66.75% 85% B 86% B+
Market Capitalization 0.53B 69% C- 61% D-

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.